138 related articles for article (PubMed ID: 11162921)
1. Regulation of the estrogen-responsive pS2 gene in MCF-7 human breast cancer cells.
Kim J; Petz LN; Ziegler YS; Wood JR; Potthoff SJ; Nardulli AM
J Steroid Biochem Mol Biol; 2000 Nov; 74(4):157-68. PubMed ID: 11162921
[TBL] [Abstract][Full Text] [Related]
2. Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes.
Krieg AJ; Krieg SA; Ahn BS; Shapiro DJ
J Biol Chem; 2004 Feb; 279(6):5025-34. PubMed ID: 14617632
[TBL] [Abstract][Full Text] [Related]
3. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
Klinge CM
J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
[TBL] [Abstract][Full Text] [Related]
4. Two antiestrogens affect differently chromatin remodeling of trefoil factor 1 (pS2) gene and the fate of estrogen receptor in MCF7 cells.
Giamarchi C; Chailleux C; Calligé M; Rochaix P; Trouche D; Richard-Foy H
Biochim Biophys Acta; 2002 Oct; 1578(1-3):12-20. PubMed ID: 12393183
[TBL] [Abstract][Full Text] [Related]
5. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M
Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620
[TBL] [Abstract][Full Text] [Related]
6. Allosteric modulation of estrogen receptor conformation by different estrogen response elements.
Wood JR; Likhite VS; Loven MA; Nardulli AM
Mol Endocrinol; 2001 Jul; 15(7):1114-26. PubMed ID: 11435612
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H
Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
9. Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter.
Petz LN; Nardulli AM
Mol Endocrinol; 2000 Jul; 14(7):972-85. PubMed ID: 10894148
[TBL] [Abstract][Full Text] [Related]
10. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells.
Weaver CA; Springer PA; Katzenellenbogen BS
Mol Endocrinol; 1988 Oct; 2(10):936-45. PubMed ID: 2460749
[TBL] [Abstract][Full Text] [Related]
11. A unique downstream estrogen responsive unit mediates estrogen induction of proteinase inhibitor-9, a cellular inhibitor of IL-1beta- converting enzyme (caspase 1).
Krieg SA; Krieg AJ; Shapiro DJ
Mol Endocrinol; 2001 Nov; 15(11):1971-82. PubMed ID: 11682627
[TBL] [Abstract][Full Text] [Related]
12. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
Kim K; Thu N; Saville B; Safe S
Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens.
Fritah A; Redeuilh G; Sabbah M
J Endocrinol; 2006 Dec; 191(3):613-24. PubMed ID: 17170219
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
15. Estrogen regulation of trefoil factor 1 expression by estrogen receptor alpha and Sp proteins.
Sun JM; Spencer VA; Li L; Yu Chen H; Yu J; Davie JR
Exp Cell Res; 2005 Jan; 302(1):96-107. PubMed ID: 15541729
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel transferable cis element in the promoter of an estrogen-responsive gene that modulates sensitivity to hormone and antihormone.
Montano MM; Kraus WL; Katzenellenbogen BS
Mol Endocrinol; 1997 Mar; 11(3):330-41. PubMed ID: 9058379
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor alpha and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells.
Petz LN; Ziegler YS; Loven MA; Nardulli AM
Endocrinology; 2002 Dec; 143(12):4583-91. PubMed ID: 12446585
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters.
Nardulli AM; Romine LE; Carpo C; Greene GL; Rainish B
Mol Endocrinol; 1996 Jun; 10(6):694-704. PubMed ID: 8776729
[TBL] [Abstract][Full Text] [Related]
19. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
Chalbos D; Philips A; Galtier F; Rochefort H
Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI
J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
